28 December 2020

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

28 December 2020 | n=48

  1. Tordoff DM, Buskin S, Lechtenberg R, Golden MR, et al.
    Combining traditional and molecular epidemiology methods to quantify local HIV transmission among foreign-born residents of King County, Washington.
    AIDS 2020.

  2. Wood BR.
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy.
    AIDS 2020;34:2319-2320.

  3. Ragonnet-Cronin M, Benbow N, Hayford C, Poortinga K, et al.
    Sorting by race/ethnicity across HIV genetic transmission networks in three major metropolitan areas in the United States.
    AIDS Res Hum Retroviruses 2020.

  4. Kerrigan D, Murray M, Sanchez Karver T, Mantsios A, et al.
    Feasibility of implementing long-acting injectable anti-retroviral therapy to treat HIV: a survey of health providers from the 13 countries participating in the ATLAS-2M trial.
    AIDS Res Hum Retroviruses 2020.

  5. Sim JH, Sherman JB, Stanley TL, Corey KE, et al.
    Pro-inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection.
    AIDS Res Hum Retroviruses 2020.

  6. Papasavvas E, Azzoni L, Pagliuzza A, Abdel-Mohsen M, et al.
    Safety, immune and anti-viral effects of pegylated interferon alpha 2b administration in ART-suppressed individuals: Results of pilot clinical trial.
    AIDS Res Hum Retroviruses 2020.

  7. Borghetti A, Bellino S, Lombardi F, Whalen M, et al.
    Risk of tumour onset in HIV+ patients on two-drug regimens: a cohort study in an Italian hospital.
    AIDS Res Hum Retroviruses 2020.

  8. Mehta G, Sharma A, Arora SK.
    Acquisition of additional NFkappaB binding sites in LTR of genetically evolving HIV-1 subtype C viral species in host with co-morbidities.
    AIDS Res Hum Retroviruses 2020.

  9. Ard KL, Walensky RP.
    Payments for Preexposure Prophylaxis in the United States: Too Much for Too Few.
    Ann Intern Med 2020;173:844-845.

  10. Irvin R, Gamble T, Malone J, Wang Z, et al.
    HPTN 078: High Prevalence of HCV Antibodies Among Urban U.S. Men Who Have Sex with Men (MSM) Independent of HIV Status.
    Clin Infect Dis 2020.

  11. Dickinson L, Walimbwa S, Singh Y, Kaboggoza J, et al.
    Infant exposure to dolutegravir through placental and breastmilk transfer: a population pharmacokinetic analysis of DolPHIN-1.
    Clin Infect Dis 2020.

  12. Stranix-Chibanda L, Anderson PL, Kacanek D, Hosek S, et al.
    Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa.
    Clin Infect Dis 2020.

  13. Van Deun A, Decroo T.
    How second-line injectable drugs work.
    Clin Infect Dis 2020.

  14. Guaraldi G, Milic J, Martinez E, Kamarulzaman A, et al.
    HIV care models during the COVID-19 era.
    Clin Infect Dis 2020.

  15. Orkin C, Squires KE, Molina JM, Sax PE, et al.
    Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferior
    Clin Infect Dis 2020.

  16. Stoner MCD, Westreich D, Ahern J, Edwards J, et al.
    Modeling Combination Interventions to Prevent Human Immunodeficiency Virus in Adolescent Girls and Young Women in South Africa (HIV Prevention Trials Network 068).
    Clin Infect Dis 2020.

  17. Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, et al.
    Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.
    Clin Infect Dis 2020.

  18. Masyuko SJ, Page ST, Polyak SJ, Kinuthia J, et al.
    Human Immunodeficiency Virus Is Associated With Higher Levels of Systemic Inflammation Among Kenyan Adults Despite Viral Suppression.
    Clin Infect Dis 2020.

  19. Rowland-Jones S, Yindom LM, Ferrand R.
    Reply to Cevik et al.
    Clin Infect Dis 2020;70:990-991.

  20. Mistrangelo M, Dal Conte I.
    The Role of High-resolution Anoscopy and Random Biopsies: The Role of Infrared Coagulation vs Active Monitoring in the Treatment of High-grade Squamous Intraepithelial Lesions.
    Clin Infect Dis 2020;70:987.

  21. Bennett SE.
    Should Women With High-risk Human Papillomavirus Infection of the Cervix Be Screened for Anal Squamous Intraepithelial Lesions?
    Clin Infect Dis 2020;70:1129-1130.

  22. Florin TA.
    Improving Risk Stratification for Children With Pneumonia: The Journey Continues.
    Clin Infect Dis 2020;70:1058-1059.

  23. Krist AH, Davidson KW, Mangione CM, Barry MJ, et al.
    Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA 2020;324:2415-2422.

  24. Blair CS, Lake JE, Passaro RC, Chavez-Gomez S, et al.
    HIV-1 Seroconversion is Not Associated with Prolonged Rectal Mucosal Inflammation.
    J Acquir Immune Defic Syndr 2020;Publ.

  25. Petoumenos K, Kuwanda L, Ryom L, Mocroft A, et al.
    Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\.
    J Acquir Immune Defic Syndr 2020;Publ.

  26. Weiser JK, Tie Y, Beer L, Fanfair RN, et al.
    Racial/ethnic and Income Disparities in the Prevalence of Comorbidities that Are Associated With Risk for Severe COVID-19 Among Adults Receiving HIV Care, United States, 2014-2019.
    J Acquir Immune Defic Syndr 2020;Publ.

  27. Katz IT, Musinguzi N, Bell K, Cross A, et al.
    The Impact of Disease Stage on Early Gaps in ART in the "Treatment for All" Era - A Multisite Cohort Study.
    J Acquir Immune Defic Syndr 2020;Publ.

  28. Samri A, Chalouni M, Blanco J, Behrens G, et al.
    Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naive HIV-1-infected patients.
    J Acquir Immune Defic Syndr 2020;Publ.

  29. Tolentino A, Amaral S, Souza LS, Zeballos D, et al.
    Frequency of falls and associated risk factors in people living with HIV: a systematic review with meta-analysis and meta-regression.
    J Acquir Immune Defic Syndr 2020;Publ.

  30. Lederman MM.
    AIDS in the Heartland- Hemophilia was the Harbinger of Things to Come.
    J Acquir Immune Defic Syndr 2020;Publ.

  31. Chow EPF, Ong JJ, Denham I, Fairley CK, et al.
    HIV testing and diagnoses during the COVID-19 pandemic in Melbourne, Australia.
    J Acquir Immune Defic Syndr 2020;Publ.

  32. Perez-Valero I, Llibre JM, Castagna A, Pulido F, et al.
    Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation.
    J Acquir Immune Defic Syndr 2020.

  33. Hearps AC, Angelovich TA, Trevillyan JM, Wong ME, et al.
    Rosuvastatin therapy in people with HIV at intermediate cardiovascular risk does not decrease biomarkers of inflammation and immune activation.
    J Infect Dis 2020.

  34. McMahon DK, Zheng L, Cyktor JC, Aga E, et al.
    A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).
    J Infect Dis 2020.

  35. Manion M, Dulanto Chiang A, Pei L, Wong CS, et al.
    Disseminated Mycobacterium marinum in HIV unmasked by Immune Reconstitution Inflammatory Syndrome.
    J Infect Dis 2020.

  36. Kirkegaard-Klitbo DM, Bendtsen F, Lundgren J, de Knegt RJ, et al.
    Increased prevalence of liver fibrosis in people living with HIV without viral hepatitis compared to population controls.
    J Infect Dis 2020.

  37. Jiang W, Luo Z, Stephenson S, Li H, et al.
    Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury.
    J Infect Dis 2020.

  38. Sundermann EE, Bondi MW, Campbell LM, Gouaux B, et al.
    Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders.
    J Infect Dis 2020.

  39. Sarkar S, Khanna P, Singh AK.
    Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses.
    J Med Virol 2020.

  40. Annamalay AA, Abbott S, Khoo SK, Hibbert J, et al.
    The Impact of Cytokine Levels in Young South African Children with and without HIV-associated Acute Lower Respiratory Infections.
    J Med Virol 2020.

  41. Cure E, Cumhur Cure M.
    Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19".
    J Med Virol 2020.

  42. Acharya A, Olwenyi OA, Thurman M, Pandey K, et al.
    Chronic morphine administration differentially modulates viral reservoirs in SIVmac251 infected rhesus macaque model.
    J Virol 2020.

  43. Burki T.
    Cheaper HIV treatment for children.
    Lancet 2020;396:1873.

  44. Hoy J, McMahon J.
    Is it time for injectable antiretroviral therapy for HIV?
    Lancet 2021;396:1944-1946.

  45. Overton ET, Richmond G, Rizzardini G, Jaeger H, et al.
    Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
    Lancet 2021;396:1994-2005.

  46. Edridge AWD, Kaczorowska J, Hoste ACR, Bakker M, et al.
    Seasonal coronavirus protective immunity is short-lasting.
    Nat Med 2020;26:1691-1693.

  47. Zhang Z, Perkovic M, Gu Q, Balakrishnan K, et al.
    HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms.
    Virology 2020;554:17-27.

  48. Ojwach DBA, Madlala P, Gordon M, Ndung'u T, et al.
    Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Virology 2020;554:1-8.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

25 January 2021

18 January 2021

11 January 2021

04 January 2021

28 December 2020

28 December 2020

Multidisciplinary Journal Club

  1. Lu TX, Dapas M, Lin E, Peters T, et al.
    The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies.
    Gut. 2020 Dec 17. pii: gutjnl-2020-321609. doi: 10.1136/gutjnl-2020-321609.

  2. Croop R, Lipton RB, Kudrow D, Stock DA, et al.
    Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Dec 15. pii: S0140-6736(20)32544.

  3. Yang X, Leslie G, Doroszuk A, Schneider S, et al.
    Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
    J Clin Oncol. 2020;38:674-685.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016